OralParenteralDosed ingredient

Potassium Chloride

CAS 7447-40-7

Potassium Chloride (CAS 7447-40-7) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 8,747 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

8,747

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Potassium Chloride

CAS Number

7447-40-7

UNII

660YQ98I10

InChIKey

WCUXLLCKKVVCTQ-UHFFFAOYSA-M

ChEMBL ID

CHEMBL1200731

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

dosed ingredientoralparenteral

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)

Approved or marketed human pharmaceutical use is represented in the source phase field.

ChEMBL CHEMBL1200731 | Small molecule

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Ki	90000 nM	1	-
Carbonic anhydrase 4 Enzyme	Ki	4.05	-	Homo sapiens

SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Drug ineffective	1839	1159.42	10013709
Hyperkalaemia	1263	652.556	10020646
Hypokalaemia	1481	651.491	10021015
Pemphigus	3	610.601	10034280
Cardiac failure congestive	1447	571.623	10007559
Hand deformity	7	510.378	10061194
Systemic lupus erythematosus	62	498.919	10042945
Contraindicated product administered	131	442.223	10078504
Acute kidney injury	3128	442.133	10069339
Glossodynia	56	422.978	10018388
Off label use	2174	384.224	10053762
Atrial fibrillation	1574	383.699	10003658
Anti-cyclic citrullinated peptide antibody positive	4	370.653	10068798
Oedema peripheral	1831	352.218	10030124
Alopecia	398	340.861	10001760
Toxic anterior segment syndrome	177	340.191	10066366
Therapeutic product effect decreased	155	339.912	10082201
Rheumatoid arthritis	267	339.17	10039073
Joint swelling	447	331.298	10023232
Arthropathy	225	327.593	10003285
Dehydration	1742	316.332	10012174
Treatment failure	221	306.656	10066901
Pericarditis	54	303.714	10034484
Drug intolerance	452	301.797	10061822
Blood potassium decreased	592	301.616	10005724
Pneumonia	3773	292.523	10035664
Wound	113	288.678	10052428
Anaemia	2660	284.795	10002034
Hypervolaemia	504	280.478	10020919
Cardiac failure	1184	277.224	10007554
Maternal exposure during pregnancy	201	267.45	10071408
Drug abuse	88	267.099	10013654
Abdominal discomfort	517	256.62	10000059
Duodenal ulcer perforation	10	255.794	10013849
Musculoskeletal stiffness	216	251.235	10052904
Hypotension	2438	246.49	10021097
Lower respiratory tract infection	107	246.477	10024968
Synovitis	178	245.737	10042868
Helicobacter infection	21	242.802	10054263
Toxicity to various agents	669	241.525	10070863
Dyspnoea	4435	239.615	10013968
Arthralgia	1370	234.211	10003239
Pulmonary hypertension	523	231.089	10037400
Infusion related reaction	413	230.187	10051792
Pulmonary arterial hypertension	356	218.85	10064911
Plasma cell myeloma	608	215.191	10035226
Discomfort	175	213.325	10013082
Product use issue	390	211.172	10076309
Right ventricular failure	315	208.878	10039163
Fluid retention	630	192.278	10016807

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 5 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
Potassium Chloride	8591	SU	MTHSPL
Potassium chloride	8591	SU	MTHSPL
potassium chloride	8591	SU	MTHSPL
POTASSIUM CHLORIDE	8591	SU	MTHSPL
potassium chloride	8591	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Potassium Chloride used for in pharmaceutical contexts?

Potassium Chloride (CAS 7447-40-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Potassium Chloride?

Potassium Chloride has 8,747 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Drug ineffective, Hyperkalaemia, Hypokalaemia, Pemphigus, Cardiac failure congestive. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Potassium Chloride also used in cosmetics?

No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Potassium Chloride.

What clinical phase is Potassium Chloride in?

Potassium Chloride is rendered with ChEMBL max phase 4 (approved).

What bioactivity targets are documented for Potassium Chloride?

Potassium Chloride has 2 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 4.